Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-25T18:08:22.340Z Has data issue: false hasContentIssue false

Chapter 4 - Serotonin syndrome

Published online by Cambridge University Press:  05 July 2015

By
Dimitrios A. Nacopoulos  and
Hubert H. Fernandez
Edited by
Joseph H. Friedman
Joseph H. Friedman
Affiliation:
Department of Neurology, Brown University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Medication-Induced Movement Disorders , pp. 44 - 52
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Boyer, EW, Shannon, M. The serotonin syndrome. N Engl J Med 2005;352:1112–20.CrossRefGoogle ScholarPubMed
Sporer, KA. The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Saf 1995;13(2):94–104.CrossRefGoogle ScholarPubMed
Mackay, FJ, Dunn, NR, Mann, RD. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract 1999;49:871–4.Google ScholarPubMed
Isbister, GK, Bowe, SJ, Dawson, A, Whyte, IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004;42:277–85.CrossRefGoogle ScholarPubMed
Sternbach, H. The serotonin syndrome. Am J Psychiatry 1991;148:705–13.Google ScholarPubMed
Gill, M, LoVecchio, F, Selden, B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999;33:457–9.CrossRefGoogle Scholar
Arora, B, Kannikeswaran, N. The serotonin syndrome – the need for physician’s awareness. Int J Emerg Med 2010;3(4):373–77.CrossRefGoogle ScholarPubMed
Gillman, PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998;12(5):482–91.CrossRefGoogle ScholarPubMed
Insel, TR, Roy, BF, Cohen, RM, Murphy, DL. Possible development of the serotonin syndrome in man. Am J Psychiatry 1982;139(7):954–5.Google ScholarPubMed
Asch, DA, Parker, RM. The Libby Zion case: one step forward or two steps backward? N Engl J Med 1988;318:771–5.CrossRefGoogle ScholarPubMed
Dunkley, EJ, Isbister, GK, Sibbritt, D, Dawson, AH, Whyte, IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003;96:635–42.CrossRefGoogle ScholarPubMed
Nisijima, K, Shioda, K, Yoshino, T, Takano, K, Kato S. Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. Pharmacopsychiatry 2004;37:57–62.Google Scholar
Smith, B, Prockop, DJ. Central-nervous-system effects of ingestion of L-tryptophan by normal subjects. N Engl J Med 1962;267:1338–1341.CrossRefGoogle ScholarPubMed
Buckley, NA, Dawson, AH, Isbister, GK. Serotonin syndrome. BMJ 2014;348:g1626.CrossRefGoogle ScholarPubMed
Evans, RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. MedGenMed 2007;9(3):48.Google ScholarPubMed
Evans, RW, Tepper, SJ, Shapiro, RE, Sun-Edelstein, C, Tietjen, GE. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache 2010 Jun:50(6);1089–99.CrossRefGoogle ScholarPubMed
Hegerl, U, Bottlender, R, Gallinat, J, Kuss, HJ, Ackenheil, M, Moller, HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998;248:96–103.CrossRefGoogle ScholarPubMed
Radomski, JW, Dursun, SM, Reveley, MAKSP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 1999;218–24.CrossRefGoogle Scholar
MacLennan, DH, Duff, C, Zorzato, F, Fujii, J, Phillips, M, Korneluk, RG, Frodis, W, Britt, BA, Wortont, RG. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 1990;343:559–61.CrossRefGoogle ScholarPubMed
Rosenberg, H, Davis, M, James, D, Pollock, N, Stowell, K. Malignant hyperthermia. Orphanet J Rare Dis 2007; 24:2–21.Google Scholar
Strawn, JR, Keck, PE, Caroff, SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164(6):870–6.CrossRefGoogle ScholarPubMed
Caroff, SN, Mann, SC. Neuroleptic malignant syndrome. Psychopharmocol Bull 1988;24:25–29.Google ScholarPubMed
Nisijima, K, Yoshino, T, Yui, K, Katoh, S. Potent serotonin (5-HT2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 2001;890:23–31.CrossRefGoogle Scholar
Graudins, A, Stearman, A, Chan, B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1988;16:615–9.Google Scholar
Snider, SR, Hutt, C, Stein, B, Fahn, S. Increase in brain serotonin produced by bromocriptine. Neurosci Lett 1975;1:237–41.CrossRefGoogle Scholar
Porcelli, S, Drago, A, Fabbri, C, Gibiino, S, Calati, R, Serretti, A. Pharmacogenetics of antidepressant response. J Psychiatry Neurosci 2011;36:87–113.CrossRefGoogle ScholarPubMed
Wimbiscus, M, Kostenko, O, Malone, D. MAO inhibitors: risks, benefits, and lore. Cleve Clin J Med. 2010 Dec;77(12):859–82.CrossRefGoogle ScholarPubMed
Selegiline [package insert]. Morgantown, WV: Mylan Pharmaceuticals; 2009.Google Scholar
Azilect [package insert]. Kansas City, MO: Teva Neuroscience; 2009.Google Scholar
Richard, IH, Kurlan, R, Tanner, C, et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson’s disease. Neurology. 1997;48:1070–7.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×